Seizures and hepatotoxicity following sulphasalazine administration

Rheumatology International

Volumn 17, Issue 2, 1997, Pages 75-77

  Senturk T ^a,b   Aydintug A O ^a   Duzgun N ^a   Tokgoz G ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Adverse drug reaction; Hepatotoxicity; Seizures; Sulphasalazine

Indexed keywords

ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY DIAGNOSIS; LIVER TOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; RHEUMATIC DISEASE; SEIZURE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS; CHRONIC DISEASE; FEMALE; HUMANS; LIVER; LIVER DISEASES; SEIZURES; SULFASALAZINE;

EID: 0030789930     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960050012     Document Type: Article

References (15)

1. Day RO (1993) Sulfasalazine. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. Saunders, Philadelphia, pp 692-699
2. Amos RS (1995) The history of the use of sulphasalazine in rheumatology. Br J Rheumatol 34: 2-6
3. Van Riel PLCM, Van Gestel AM, Van De Putte LBA (1995) Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis. Br J Rheumatol 34: 40-42
4. Amos RS, Pullar TT, Bax DE, et al. (1986) Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J 293: 420-423
5. Situnayake RD, Grindulis KA, McConkey B (1987) Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis 46: 177- 183
6. McConkey B, Amos RS, Butler EP, et al. (1994) Salazopyrin in rheumatoid arthritis. Agents Actions 43: 202-205
7. Farr M, Scatt DGI, Bacon PA (1986) Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine. Drugs 32: 49-53
8. Smith MD, Gibson GE, Rowland R (1982) Combined hepatotoxicity and neurotoxicity following sulphasalazine administration. Aust NZJ Med 12: 76-80
9. American College of Rheumatology Ad Hoc Comittee on Clinical Guidelines (1996) Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 39: 723-731
10. Hill ME, Gordon C, Situnayake RD, Heath DA (1994) Sulfasalazine induced seizures and dysphasia. J Rheumatol 21: 748-749
11. Schoonjans R, Mast A, Van Den Abeele G, et al. (1993) Sulfasalazine-associated encephalopathy in a patient with Crohn's disease. Am J Gastroenterol 88: 1416-1420
12. Smedegard G, Björk J (1995) Sulphasalazine: mechanism of action in rheumatoid arthritis. Br J Rheumatot 34: 7-15
13. Bird HA (1995) Sulphasalazine, sulphapyridine or 5-aminosalicylic acid - which is the active moiety in rheumatoid arthritis? Br J Rheumatol 34: 16-19
14. Bax DE, Amos RS (1985) Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Ann Rheum Dis 44: 194-198
15. Laversuch CJ, Collins DA, Charles PJ, Bourke BE (1995) Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic diseases. Br J Rheumatol 34: 435-439